CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Assets
Cash and due from banks	$ 508,887	$ 411,412
Interest bearing deposits with banks	714,810	1,478,713
Investment securities:
Equity securities	74,425	71,513
Available for sale debt securities	3,658,704	3,369,724
Held to maturity debt securities (net of allowance for credit losses of $633 at March 31, 2025 and $647 at December 31, 2024)	3,545,328	3,531,573
Total investment securities	7,278,457	6,972,810
Loans held for sale (includes fair value of $8,427 at March 31, 2025 and $16,931 at December 31, 2024 for loans originated for sale)	27,377	25,681
Loans	48,657,128	48,799,711
Less: Allowance for loan losses	(578,200)	(558,850)
Net loans	48,078,928	48,240,861
Premises and equipment, net	344,123	350,796
Lease right of use assets	334,013	328,475
Bank owned life insurance	733,135	731,574
Accrued interest receivable	238,326	239,941
Goodwill	1,868,936	1,868,936
Other intangible assets, net	121,340	128,661
Other assets	1,617,323	1,713,831
Total Assets	61,865,655	62,491,691
Deposits:
Non-interest bearing	11,628,578	11,428,674
Interest bearing:
Savings, NOW and money market	26,413,258	26,304,639
Time	11,924,008	12,342,544
Total deposits	49,965,844	50,075,857
Short-term borrowings	59,026	72,718
Long-term borrowings	2,904,567	3,174,155
Junior subordinated debentures issued to capital trusts	57,542	57,455
Lease liabilities	394,334	388,303
Accrued expenses and other liabilities	984,445	1,288,076
Total Liabilities	54,365,758	55,056,564
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 560,278,101 shares at March 31, 2025 and 558,786,093 shares at December 31, 2024)	196,520	195,998
Surplus	5,444,756	5,442,070
Retained earnings	1,634,690	1,598,048
Accumulated other comprehensive loss	(128,252)	(155,334)
Treasury stock, at cost (250,000 common shares at March 31, 2025)	(2,162)	0
Total Shareholders’ Equity	7,499,897	7,435,127
Total Liabilities and Shareholders’ Equity	61,865,655	62,491,691
Series A
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	98,101	98,101
Series C
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	$ 144,654	$ 144,654